The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (e{open}-caprolactone)/collagen fibers and hyaluronic acid hydrogel

Biomaterials

Volumn 32, Issue 32, 2011, Pages 8108-8117

  Ekaputra, Andrew K ^a   Prestwich, Glenn D ^b   Cool, Simon M ^c   Hutmacher, Dietmar W ^d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF UTAH   (United States)

^c INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Angiogenesis; Collagen; Endothelial cell; Hyaluronic acid hyaluronan; Polycaprolactone; Scaffold

Indexed keywords

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; CAPILLARY NETWORK; CAPROLACTONE; CELLULAR ATTACHMENTS; COCULTURE; CONTROLLED RELEASE; ENGINEERED TISSUES; GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYALURONIC ACID HYDROGELS; HYALURONIC ACID/HYALURONAN; HYALURONIC ACIDS; HYBRID MESHES; HYBRID SCAFFOLDS; IN-VITRO; PDGF BB'S; SIMULTANEOUS DEPOSITION; STUMBLING BLOCKS; THREE-DIMENSIONAL (3D); VASCULARIZATION; VASCULARIZED TISSUES;

BIOACTIVITY; CELL CULTURE; COLLAGEN; ENDOTHELIAL CELLS; HYDROGELS; ORGANIC ACIDS; PEPTIDES; SCAFFOLDS (BIOLOGY); SEEPAGE; SOIL MECHANICS; TISSUE;

THREE DIMENSIONAL;

HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR BB; POLYCAPROLACTONE; TISSUE SCAFFOLD; VASCULOTROPIN 165;

ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; LUNG FIBROBLAST; PRIORITY JOURNAL; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; CATTLE; CELL SHAPE; COCULTURE TECHNIQUES; FIBRILLAR COLLAGENS; FIBROBLASTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYALURONIC ACID; HYDROGEL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYESTERS; TISSUE SCAFFOLDS;

EID: 80052345868     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.022     Document Type: Article

References (68)

1. Cancedda R., Dozin B., Giannoni P., Quarto R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 2003, 22(1):81-91.
2. Cao Y., Croll T.I., Lees J.G., Tuch B.E., Cooper-White J.J. Scaffolds, stem cells, and tissue engineering: a potent combination!. Aust J Chem 2005, 58(10):691-703.
3. Li D., Xia Y.N. Electrospinning of nanofibers: reinventing the wheel?. Adv Mater 2004, 16(14):1151-1170.
4. Bashur C.A., Dahlgren L.A., Goldstein A.S. Effect of fiber diameter and orientation on fibroblast morphology and proliferation on electrospun poly(d, l-lactic-co-glycolic acid) meshes. Biomaterials 2006, 27(33):5681-5688.
5. Badami A.S., Kreke M.R., Thompson M.S., Riffle J.S., Goldstein A.S. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials 2006, 27(4):596-606.
6. Li W.J., Danielson K.G., Alexander P.G., Tuan R.S. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A 2003, 67A(4):1105-1114.
7. Carampin P., Conconi M.T., Lora S., Menti A.M., Baiguera S., Bellini S., et al. Electrospun polyphosphazene nanofibers for in vitro rat endothelial cells proliferation. J Biomed Mater Res 2007, 80(3):661-668.
8. He W., Ma Z., Yong T., Teo W.E., Ramakrishna S. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 2005, 26(36):7606-7615.
9. Jin H.J., Chen J.S., Karageorgiou V., Altman G.H., Kaplan D.L. Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials 2004, 25(6):1039-1047.
10. Min B.M., Lee G., Kim S.H., Nam Y.S., Lee T.S., Park W.H. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004, 25(7-8):1289-1297.
11. Mo X.M., Xu C.Y., Kotaki M., Ramakrishna S. Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. Biomaterials 2004, 25(10):1883-1890.
12. Shin H.J., Lee C.H., Cho I.H., Kim Y.J., Lee Y.J., Kim I.A., et al. Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: mechanical stability, degradation and cellular responses under mechanical stimulation in vitro. J Biomat Sci-Polym E 2006, 17(1-2):103-119.
13. Venugopal J.R., Zhang Y.Z., Ramakrishna S. in vitro culture of human dermal fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane. Artif Organs 2006, 30(6):440-446.
14. Ekaputra A.K., Prestwich G.D., Cool S.M., Hutmacher D.W. Combining electrospun scaffolds with electrosprayed hydrogels leads to three-dimensional cellularization of hybrid constructs. Biomacromolecules 2008, 9(8):2097-2103.
15. Rouwkema J., Rivron N.C., van Blitterswijk C.A. Vascularization in tissue engineering. Trends Biotechnol 2008, 26(8):434-441.
16. Soker S., Machado M., Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000, 18(1):10-18.
17. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006, 12(8):2093-2104.
18. Vogel V., Baneyx G. The tissue engineering puzzle: a molecular perspective. Annu Rev Biomed Eng 2003, 5:441-463.
19. Biondi M., Ungaro F., Quaglia F., Netti P.A. Controlled drug delivery in tissue engineering. Adv Drug Deliver Rev 2008, 60(2):229-242.
20. Epstein S.E., Kornowski R., Fuchs S., Dvorak H.F. Angiogenesis therapy - amidst the hype, the neglected potential for serious side effects. Circulation 2001, 104(1):115-119.
21. Jain R.K. Molecular regulation of vessel maturation. Nat Med 2003, 9(6):685-693.
22. Liekens S., De Clercq E., Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001, 61(3):253-270.
23. Phelps E.A., Garcia A.J. Update on therapeutic vascularization strategies. Regen Med 2009, 4(1):65-80.
24. Eichhorn S.J., Sampson W.W. Statistical geometry of pores and statistics of porous nanofibrous assemblies. J R Soc Interface 2005, 2(4):309-318.
25. Li M., Mondrinos M.J., Chen X., Gandhi M.R., Ko F.K., Lelkes P.I. Co-electrospun poly(lactide-co-glycolide), gelatin, and elastin blends for tissue engineering scaffolds. J Biomed Mater Res A 2006, 79A(4):963-973.
26. Jeong S.I., Lee A.Y., Lee Y.M., Shin H. Electrospun gelatin/poly(l-lactide-co-epsilon-caprolactone) nanofibers for mechanically functional tissue-engineering scaffolds. J Biomat Sci-Polym Ed 2008, 19(3):339-357.
27. Yang X.B., Roach H.I., Clarke N.M.P., Howdle S.M., Quirk R., Shakesheff K.M., et al. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001, 29(6):523-531.
28. Ekaputra A.K., Zhou Y., Cool S., Hutmacher D.W. Composite electrospun scaffolds for engineering tubular bone grafts. Tissue Eng Pt A 2009, 15(12):3779-3788.
29. Green J.A., Yamada K.M. Three-dimensional microenvironments modulate fibroblast signaling responses. Adv Drug Deliver Rev 2007, 59(13):1293-1298.
30. Schindler M., Nur-E-Kamal A., Ahmed I., Kamal J., Liu H.Y., Amor N., et al. Living in three dimensions - 3D nanostructured environments for cell culture and regenerative medicine. Cell Biochem Biophys 2006, 45(2):215-227.
31. Schindler M., Ahmed I., Kamal J., Nur-E-Kamal A., Grafe T.H., Chung H.Y., et al. A synthetic nanofibrillar matrix promotes in vivo-like organization and morphogenesis for cells in culture. Biomaterials 2005, 26(28):5624-5631.
32. Stevens D.A., Williams G.R. Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 1999, 151(1-2):195-204.
33. Lee J., Cuddihy M.J., Kotov N.A. Three-dimensional cell culture matrices: state of the art. Tissue Eng Pt B-Rev 2008, 14(1):61-86.
34. Cukierman E., Pankov R., Stevens D.R., Yamada K.M. Taking cell-matrix adhesions to the third dimension. Science 2001, 294(5547):1708-1712.
35. Cukierman E., Pankov R., Yamada K.M. Cells interactions with three dimensional matrices. Curr Opin Cell Biol 2002, 14:633-639.
36. Berthod F., Germain L., Tremblay N., Auger F.A. Extracellular matrix deposition by fibroblasts is necessary to promote capillary-like tube formation in vitro. J Cell Physiol 2006, 207(2):491-498.
37. Martin T.A., Harding K.G., Jiang W.G. Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis 1999, 3(1):69-76.
38. Berthod F., Sahuc F., Hayek D., Damour O., Collombel C. Deposition of collagen fibril bundles by long-term culture of fibroblasts in a collagen sponge. J Biomed Mater Res 1996, 32(1):87-93.
39. Hartlapp I., Abe R., Saeed R.W., Peng T., Voelter W., Bucala R., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001, 15(12):2215-2224.
40. Mansbridge J.N., Liu K., Pinney R.E., Patch R., Ratcliffe A., Naughton G.K. Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers. Diabetes Obes Metab 1999, 1(5):265-279.
41. Serini G., Ambrosi D., Giraudo E., Gamba A., Preziosi L., Bussolino F. Modeling the early stages of vascular network assembly. EMBO J 2003, 22(8):1771-1779.
42. Yang E.Y., Moses H.L. Transforming growth factor-beta-1-induced changes in cell-migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990, 111(2):731-741.
43. Nakagawa S., Pawelek P., Grinnell F. Extracellular-matrix organization modulates fibroblast growth and growth-factor responsiveness. Exp Cell Res 1989, 182(2):572-582.
44. Nakagawa S., Pawelek P., Grinnell F. Long-term culture of fibroblasts in contracted collagen gels - effects on cell-growth and biosynthetic activity. J Invest Dermatol 1989, 93(6):792-798.
45. Drake CJ, Hungerford JE, Little CD, editors. Morphogenesis of the first blood vessels. Conference on Morphogenesis - Cellular Interactions. Bethesda, Maryland; 1997 Oct 20-23.
46. Darland D.C., D'Amore P.A. Blood vessel maturation: vascular development comes of age. J Clin Invest 1999, 103(2):157-158.
47. Risau W. Mechanisms of angiogenesis. Nature 1997, 386(6626):671-674.
48. Folkman J., Damore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87(7):1153-1155.
49. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407(6801):242-248.
50. Benjamin L.E., Hemo I., Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998, 125(9):1591-1598.
51. Ashikari-Hada S., Habuchi H., Kariya Y., Kimata K. Heparin regulates vascular endothelial growth factor(165)-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells - comparison of the effects of heparin and modified heparins. J Biol Chem 2005, 280(36):31508-31515.
52. Rolny C., Spillmann D., Lindahl U., Claesson-Welsh L. Heparin amplifies platelet-derived growth factor (PDGF)-BB-induced PDGF alpha-receptor but not PDGF beta-receptor tyrosine phosphorylation in heparan sulfate-deficient cells - effects on signal transduction and biological responses. J Biol Chem 2002, 277(22):19315-19321.
53. Tessmar J.K., Gopferich A.M. Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliver Rev 2007, 59(4-5):274-291.
54. Peattie R.A., Pike D.B., Yu B., Cai S., Shu X.Z., Prestwich G.D., et al. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv 2008, 15(6):389-397.
55. Hile D.D., Amirpour M.L., Akgerman A., Pishko M.V. Active growth factor delivery from poly(d, l-lactide-co-glycolide) foams prepared in supercritical CO2. J Control Release 2000, 66(2-3):177-185.
56. Ziegler J., Mayr-Wohlfart U., Kessler S., Breitig D., Gunther K.P. Adsorption and release properties of growth factors from biodegradable implants. J Biomed Mater Res 2002, 59(3):422-428.
57. Gu F., Neufeld R., Amsden B. Sustained release of bioactive therapeutic proteins from a biodegradable elastomeric device. J Control Release 2007, 117(1):80-89.
58. Goolcharran C., Cleland J.L., Keck R., Jones A.J.S., Borchardt R.T. Comparison of the rates of deamidation, diketopiperazine formation, and oxidation in recombinant human vascular endothelial growth factor and model peptides. AAPS Pharmsci 2000, 2(1):1-6.
59. Davis G.E., Bayless K.J., Mavila A. Molecular basis of endothelial cell morphogenesis in three-dimensional extracellular matrices. Anat Rec 2002, 268(3):252-275.
60. Donovan D., Brown N.J., Bishop E.T., Lewis C.E. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 2001, 4(2):113-121.
61. Ingber D.E., Folkman J. How does extracellular-matrix control capillary morphogenesis. Cell 1989, 58(5):803-805.
62. Sweeney S.M., DiLullo G., Slater S.J., Martinez J., Iozzo R.V., Lauer-Fields J.L., et al. Angiogenesis in collagen I requires alpha2beta1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly. J Biol Chem 2003, 278(33):30516-30524.
63. Tonello C., Vindigni V., Zavan B., Abatangelo S., Abatangelo G., Brun P., et al. in vitro reconstruction of an endothelialized skin substitute provided with a microcapillary network using biopolymer scaffolds. FASEB J 2005, 19(8):1546-1560.
64. Kunz-Schughart L.A., Schroeder J.A., Wondrak M., van Rey F., Lehle K., Hofstaedter F., et al. Potential of fibroblasts to regulate the formation of three-dimensional vessel-like structures from endothelial cells in vitro. Am J Physiol 2006, 290(5):C1385-C1398.
65. Benjamin L.E., Golijanin D., Itin A., Pode D., Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Inves 1999, 103(2):159-165.
66. Nehls V., Schuchardt E., Drenckhahn D. The effect of fibroblasts, vascular smooth muscle cells, and pericytes on sprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvasc Res 1994, 48(3):349-363.
67. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001, 19(11):1029-1034.
68. Koike N., Fukumura D., Gralla O., Au P., Schechner J.S., Jain R.K. Creation of long-lasting blood vessels. Nature 2004, 428(6979):138-139.